Mitochondria in Amyotrophic Lateral Sclerosis
Mitochondria in Amyotrophic Lateral Sclerosis
批准号:
6641494
负责人:
M FLINT BEAL
金额:
$22.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2007-11-30
关键词:
amyotrophic lateral sclerosis cellular respiration enzyme structure genetically modified animals human tissue laboratory mouse mitochondrial DNA mitochondrial disease /disorder molecular pathology motor neurons patient oriented research postmortem superoxide dismutase synaptosomes tissue /cell culture
中文摘要
肌萎缩性侧索硬化症(ALS)是一种毁灭性的神经退行性疾病,它影响脊髓和大脑皮层的运动神经元,导致进行性瘫痪和过早死亡。虽然大多数病例是散发的,原因不明,但约有5-10%是家族性的(FALS),其中约25%与Cu/Zn超氧化物歧化酶(SOD1)基因突变有关。这些突变是第一个被确定的ALS的原因,他们的发现使得这种疾病的转基因小鼠模型得以发展。
英文摘要
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, which affects motor neurons of the spinal cord and cerebral cortex, leading to progressive paralysis and premature death. While the majority of the cases are sporadic and due to unknown causes, about 5-10% are familial (FALS), and of those approximately 25% are associated with mutations in the gene for Cu/Zn superoxide dismutase (SOD1). These mutations are the first identified cause of ALS, and their finding has allowed the development of a transgenic mouse model of the disease.
Abnormal mitochondria and impaired mitochondrial respiratory chain function have been reported in motor neurons of patients with sporadic and ALS, as well as in the mouse models. A growing body of evidence suggests that impaired mitochondrial energy production and increased oxidative radical formation in the mitochondria and damage to the mitochondrial DNA (mtDNA) could be causally involved in motor neuron death in ALS. Indeed, several studies have postulated the involvement of mtDNA abnormalities in motor neuron degeneration.
To define the role of mitochondrial alterations in the pathogenesis of ALS, we propose the following studies. 1) Analyze mitochondrial functions in brain and spinal cord in ALS transgenic mice at various stages of disease and in cultured cells expressing mutant human SOD1. Analyze the mtDNA from ALS transgenic mice in cybrids constructed with synaptosomes from brain and spinal cords. 2) Study the structural properties and the functional effects of SOD1 localized to mitochondria in transgenic animals and in cultured neuroblastoma cells expressing wild type and mutated h SOD1. 3) Analyze respiratory chain functions and mtDNA in individual motor neurons from ALS patients.
We think that a better comprehension of the molecular basis of mitochondrial dysfunction in ALS will help us to understand the mechanisms responsible for the motor neuron loss and, in some cases may even identify the primary cause of the disease, with a potential impact on therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntington's Disease
-
批准号:9197703
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2015
-
负责人:M FLINT BEAL
-
依托单位:
NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntington's Disease
-
批准号:8888600
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2015
-
负责人:M FLINT BEAL
-
依托单位:
Biomarkers of Oxidative Stress in Parkinson's Disease
-
批准号:7933687
-
项目类别:
-
资助金额:$71.8万
-
财政年份:2009
-
负责人:M FLINT BEAL
-
依托单位:
Biomarkers of Oxidative Stress in Parkinson's Disease
-
批准号:7853567
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2009
-
负责人:M FLINT BEAL
-
依托单位:
Interactions for Pesticides, mitochondria and genetics in Parkinson's disease.
-
批准号:7635654
-
项目类别:
-
资助金额:$48.14万
-
财政年份:2009
-
负责人:M FLINT BEAL
-
依托单位:
Mitochondria and Oxidative Stress in Neurodegenerative Disorders
-
批准号:7327395
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2007
-
负责人:M FLINT BEAL
-
依托单位:
Antioxidant Approaches to Alzheimer's Disease Therapy
-
批准号:7020246
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2006
-
负责人:M FLINT BEAL
-
依托单位:
Antioxidant Approaches to Alzheimer's Disease Therapy
-
批准号:7229871
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2006
-
负责人:M FLINT BEAL
-
依托单位:
Effects of Coenzyme Q10 in Parkinson Disease-Phase 3
-
批准号:6966285
-
项目类别:
-
资助金额:$220.66万
-
财政年份:2005
-
负责人:M FLINT BEAL
-
依托单位:
MITOCHONDRIA AND NEURODEGENERATION IN TRANSGENIC MICE
-
批准号:6926911
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2005
-
负责人:M FLINT BEAL
-
依托单位:
Effects of Coenzyme Q10 in Parkinson Disease-Phase 3
-
批准号:7614278
-
项目类别:
-
资助金额:$577.78万
-
财政年份:2005
-
负责人:M FLINT BEAL
-
依托单位:
Effects of Coenzyme Q10 in Parkinson Disease-Phase 3
-
批准号:7127665
-
项目类别:
-
资助金额:$130.0万
-
财政年份:2005
-
负责人:M FLINT BEAL
-
依托单位:
Development of New Therapies for Huntington's Disease
-
批准号:7230522
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2004
-
负责人:M FLINT BEAL
-
依托单位:
Development of New Therapies for Huntington's Disease
-
批准号:6811266
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2004
-
负责人:M FLINT BEAL
-
依托单位:
Development of New Therapies for Huntington's Disease
-
批准号:7061731
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2004
-
负责人:M FLINT BEAL
-
依托单位:
Development of New Therapies for Huntington's Disease
-
批准号:7479261
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2004
-
负责人:M FLINT BEAL
-
依托单位:
Development of New Therapies for Huntington's Disease
-
批准号:6915083
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2004
-
负责人:M FLINT BEAL
-
依托单位:
OXIDATIVE DAMAGE AND MITOCHONDRIAL DYSFUNCTION
-
批准号:6609882
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2002
-
负责人:M FLINT BEAL
-
依托单位:
Mitochondrial Dysfunction in Alzheimer's Disease
-
批准号:6533966
-
项目类别:
-
资助金额:$32.54万
-
财政年份:2001
-
负责人:M FLINT BEAL
-
依托单位:
OXIDATIVE DAMAGE AND MITOCHONDRIAL DYSFUNCTION
-
批准号:6475050
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2001
-
负责人:M FLINT BEAL
-
依托单位:
海外基金